Maravai LifeSciences (MRVI) Tops Q4 EPS by 2c, Revenues Beat; Offers FY21 EPS/Revenue Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. HOOD
10. IBM

Go back to Maravai LifeSciences (MRVI) Tops Q4 EPS by 2c, Revenues Beat; Offers FY21 EPS/Revenue Guidance Above Consensus
(NASDAQ: MRVI) Delayed: 5.25 +0.05 (0.96%)
Previous Close $5.20    52 Week High $ 
Open $5.28    52 Week Low $ 
Day High $5.33    P/E N/A 
Day Low $5.09    EPS $ 
Volume 1,468,422